Publication | Closed Access

Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities

Medicinal ChemistryRegioselective ModulationMedicineTopoisomerase Ii InhibitoryDna Crosslinking ActivitiesAnti-cancer AgentPharmacologyRadiation OncologyLung CancerDrug Discovery